BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24018647)

  • 1. Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial.
    de Mulder M; Umans VA; Cornel JH; van der Zant FM; Stam F; Oemrawsingh RM; Akkerhuis KM; Boersma E
    JAMA Intern Med; 2013 Nov; 173(20):1896-904. PubMed ID: 24018647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial.
    de Mulder M; Umans VA; Stam F; Cornel JH; Oemrawsingh RM; Boersma E
    Diabet Med; 2011 Oct; 28(10):1168-75. PubMed ID: 21480974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.
    Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF
    Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an optimized treatment with insulin on platelet reactivity after discharge in patients with an acute coronary syndrome and hyperglycemia.
    Vivas D; García-Rubira JC; Bernardo E; Angiolillo DJ; Martín P; Calle A; Núñez-Gil I; Macaya C; Fernández-Ortiz A
    Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):22-7. PubMed ID: 24774260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leading symptoms of chest pain in the emergency room. Using cardiac markers for risk stratification].
    Walter S; Carlsson J; Cuneo A; Tebbe U
    Dtsch Med Wochenschr; 2001 Jul; 126(27):771-8. PubMed ID: 11486476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial.
    Badings EA; The SH; Dambrink JH; van Wijngaarden J; Tjeerdsma G; Rasoul S; Timmer JR; van der Wielen ML; Lok DJ; van 't Hof AW
    EuroIntervention; 2013 May; 9(1):54-61. PubMed ID: 23685295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia.
    Staszewski J; Brodacki B; Kotowicz J; Stepien A
    J Stroke Cerebrovasc Dis; 2011; 20(2):150-4. PubMed ID: 20621520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose normalization and outcomes in patients with acute myocardial infarction.
    Kosiborod M; Inzucchi SE; Krumholz HM; Masoudi FA; Goyal A; Xiao L; Jones PG; Fiske S; Spertus JA
    Arch Intern Med; 2009 Mar; 169(5):438-46. PubMed ID: 19273773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
    Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
    Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
    Lincoff AM; Tardif JC; Schwartz GG; Nicholls SJ; Rydén L; Neal B; Malmberg K; Wedel H; Buse JB; Henry RR; Weichert A; Cannata R; Svensson A; Volz D; Grobbee DE;
    JAMA; 2014 Apr; 311(15):1515-25. PubMed ID: 24682069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of acute hyperglycaemia on the in-hospital and long-term prognosis in patients with an acute coronary syndrome--a pilot study.
    Bryniarski L; Terlecki M; Bednarek A; Kocowska M; Szynal S; Kawecka-Jaszcz K
    Kardiol Pol; 2011; 69(8):774-81. PubMed ID: 21850617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to implement a clinical pathway for intensive glucose regulation in acute coronary syndromes.
    de Mulder M; Zwaan E; Wielinga Y; Stam F; Umans VA
    Crit Pathw Cardiol; 2009 Jun; 8(2):72-8. PubMed ID: 19491573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
    Chant C; Wilson G; Friedrich JO
    Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
    Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Millán-Vázquez G; Guerrero-Molina A; Ortiz-García C; Enguix-Armada A; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E; Jiménez-Navarro MF
    Heart; 2013 Oct; 99(19):1431-7. PubMed ID: 23850844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.